BGD — Biogened SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual balance sheet for Biogened SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	PAS	PAS	PAS	PAS	PAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.55	4.97	3.46	7.51	6.07
Net Total Accounts Receivable
Net Total Receivables	23.3	23.1	19.3	17.9	19.5
Total Inventory
Total Current Assets	39.5	39.5	42.4	43.8	51
Net Property, Plant And Equipment	14.2	15.9	21.9	26.3	26.5
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	83.4	61	71.3	78.5	86.4
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	20.4	23.1	19	31.9	22.4
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	28.7	31.1	38.7	41.8	45.1
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	54.7	29.9	32.6	36.7	41.3
Total Liabilities & Shareholders' Equity	83.4	61	71.3	78.5	86.4
Total Common Shares Outstanding